Simtra BioPharma Solutions
Simtra BioPharma Solutions is an independently owned contract development and manufacturing organization (CDMO) with over 65 years of experience in sterile injectable drug products. The company operates manufacturing facilities in Bloomington, Indiana, and Halle/Westfalen, Germany, providing high-quality, cGMP-compliant sterile fill/finish services to pharmaceutical and biotech companies worldwide. Their core services include formulation development, lyophilization cycle optimization, technology transfer, analytical testing, and specialized containment for potent compounds. Simtra's manufacturing capabilities encompass a variety of sterile injectable delivery systems, such as prefilled syringes, liquid and lyophilized vials, and diluents for reconstitution. They support a wide range of product types, including biologics, cytotoxics, antibody drug conjugates, small molecules, and vaccines. With a commitment to precision and quality, Simtra partners with clients to address formulation challenges and ensure timely delivery of products to over 120 countries.
Work at Simtra BioPharma Solutions in HR or recruiting? Claim this page
Headcount trend
Simtra BioPharma Solutions went from 85 employees in Jul 2023 to 423 in Jun 2025. Jan to Jun 2025: 54 people joined, 21 left.
Headcount data through Jun 2025
Org structure
Headcount by department
Hiring now
See all jobsFunding
- Dec 2024 · $500K
Peer reviews
Worked with someone at Simtra BioPharma Solutions?
Anonymous peer reviews on OffTheRecord
Similar companies
Simtra BioPharma Solutions FAQ
How many employees does Simtra BioPharma Solutions have?
Simtra BioPharma Solutions has about 423 employees, up 3.2% over the 3 months to Jun 2025.
What is Simtra BioPharma Solutions's revenue per employee?
Simtra BioPharma Solutions makes about $1.36M in revenue per employee, based on $573.9M annual revenue and 423 employees.
How much funding has Simtra BioPharma Solutions raised?
Simtra BioPharma Solutions has raised $500K in total funding.
Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.